---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-25-000005"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T00:46:43.953515+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Intuitive Q4 rev $2.41B (+25% YoY), procedures +18%; guides 2025 procedure growth 13-16%

## Summary
- Q4 preliminary revenue $2.41B, up 25% YoY; full-year 2024 revenue $8.35B, up 17%.
- Q4 da Vinci procedures grew ~18% YoY; full-year procedures up ~17% to 2,683,000.
- 493 da Vinci systems placed in Q4 (174 da Vinci 5), up 19% YoY; 1,526 in 2024, up 11%.
- 2025 procedure growth guidance of 13-16% vs 2024.
- Q4 instruments & accessories revenue $1.41B (+23%), systems revenue $655M (+36%).

## SEC filing metadata
- accession: 0001035267-25-000005
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000005/0001035267-25-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526725000005/isrg-20250115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-25-000005
- JSON: https://secwatch.observer/filing/0001035267-25-000005.json
- Plain text: https://secwatch.observer/filing/0001035267-25-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.